Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Guangdong Transtek Medical Electronics Co., Ltd (300562.SZ)

14.39
+0.18
+(1.27%)
At close: April 30 at 3:04:49 PM GMT+8
Loading Chart for 300562.SZ
  • Previous Close 14.21
  • Open 13.95
  • Bid 14.40 x --
  • Ask 14.41 x --
  • Day's Range 14.11 - 14.50
  • 52 Week Range 7.83 - 19.10
  • Volume 11,995,800
  • Avg. Volume 18,605,831
  • Market Cap (intraday) 3.129B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 43.61
  • EPS (TTM) 0.33
  • Earnings Date --
  • Forward Dividend & Yield 0.28 (1.95%)
  • Ex-Dividend Date Apr 29, 2025
  • 1y Target Est --

Guangdong Transtek Medical Electronics Co., Ltd provides smart wearables and mobile medical care products in China and internationally. The company offers wearable sports bracelets and watches, electronic health scales, fat measuring instruments, electronic blood pressure monitors, and other hardware devices. It provides integrated software and intelligent hardware solutions for sports slimming, chronic disease management, and other fields. The company was founded in 2002 and is based in Zhongshan, China.

www.lifesense.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300562.SZ

View More

Performance Overview: 300562.SZ

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300562.SZ
2.24%
SSE Composite Index (000001.SS)
2.17%

1-Year Return

300562.SZ
55.44%
SSE Composite Index (000001.SS)
5.61%

3-Year Return

300562.SZ
70.75%
SSE Composite Index (000001.SS)
7.61%

5-Year Return

300562.SZ
9.25%
SSE Composite Index (000001.SS)
14.65%

Compare To: 300562.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300562.SZ

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    3.13B

  • Enterprise Value

    2.53B

  • Trailing P/E

    43.25

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.03

  • Price/Book (mrq)

    3.06

  • Enterprise Value/Revenue

    2.51

  • Enterprise Value/EBITDA

    33.55

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.00%

  • Return on Assets (ttm)

    2.90%

  • Return on Equity (ttm)

    6.72%

  • Revenue (ttm)

    1.01B

  • Net Income Avi to Common (ttm)

    70.64M

  • Diluted EPS (ttm)

    0.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    785.28M

  • Total Debt/Equity (mrq)

    18.94%

  • Levered Free Cash Flow (ttm)

    85.04M

Research Analysis: 300562.SZ

View More

Company Insights: 300562.SZ

Research Reports: 300562.SZ

View More

People Also Watch